The 2024 forecast data shows significant geographic disparities in bladder malignant neoplasms mortality. Hungary reports the highest rate among surveyed countries (4.7 deaths per hundred thousand women), while Mexico reports the lowest (1.1). Over the last year, notable increases occurred in Poland (3.62%) and Slovakia (3.6%), whereas Slovenia and Denmark saw declines of -4.1% and -4.84%, respectively. Over the past five years, Central and Eastern European countries have generally shown moderate to high average increases annually, while Western European countries and the US exhibit varied trajectories with some declines.
Future trends to watch:
- Rising prevalence rates in certain Eastern European regions could continue, driven by lifestyle factors and healthcare access disparities.
- Western countries may see stabilization or reductions as healthcare improvements and awareness campaigns take effect.
- Monitoring specific policy implementations aimed at improving early detection and treatment could yield impactful shifts in mortality rates globally.
Top countries in Bladder Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Hungary | 4.7 | 2023 | 0% | +1.33% | View data |
| 2 | 2 Croatia | 4.4 | 2023 | 0% | -1.31% | View data |
| 3 | 3 Poland | 4.3 | 2023 | +4.88% | +3.62% | View data |
| 4 | 4 Slovenia | 4.3 | 2023 | +2.38% | -4.1% | View data |
| 5 | 5 United Kingdom | 4 | 2023 | 0% | -0.97% | View data |
| 6 | 6 Slovakia | 3.7 | 2023 | 0% | +3.6% | View data |
| 7 | 7 Czech Republic | 3.5 | 2023 | 0% | 0% | View data |
| 8 | 8 Netherlands | 3.4 | 2023 | 0% | 0% | View data |
| 9 | 9 Luxembourg | 3.3 | 2023 | +6.45% | +0.62% | View data |
| 10 | 10 Denmark | 3.2 | 2023 | -3.03% | -4.84% | View data |
